GRAIL Announces Strategic Collaboration With AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer
MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL announced a broad strategic collaboration with AstraZeneca to develop and commercialize companion diagnostic assays.
